Tetraphase Pharmaceuticals Inc. (TTPH)

1.30
0.04 2.99
NASDAQ : Health Technology
Prev Close 1.34
Open 1.34
Day Low/High 1.26 / 1.35
52 Wk Low/High 1.01 / 4.49
Volume 572.84K
Avg Volume 736.30K
Exchange NASDAQ
Shares Outstanding 53.74M
Market Cap 73.63M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
STOCK NOTICE: Rosen Law Firm Reminds Tetraphase Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action- TTPH

STOCK NOTICE: Rosen Law Firm Reminds Tetraphase Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action- TTPH

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tetraphase Pharmaceuticals, Inc.

JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views

JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views

Doug Kass shares his views on the health of the banking sector and why he's buying biotech.

Tetraphase Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Tetraphase Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Tetraphase Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Scott + Scott, LLP Reminds Shareholders Of Important Deadline In Securities Lawsuit Against Tetraphase Pharmaceuticals Inc. -- TTPH

SHAREHOLDER ALERT: Scott + Scott, LLP Reminds Shareholders Of Important Deadline In Securities Lawsuit Against Tetraphase Pharmaceuticals Inc. -- TTPH

Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, hereby notifies investors that a class action lawsuit has been filed on behalf of all investors who purchased shares of Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals Enters Oversold Territory (TTPH)

Tetraphase Pharmaceuticals Enters Oversold Territory (TTPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial For TP-271

Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial For TP-271

First Human Patient Dosed in Trial Evaluating Novel Antibiotic Candidate Being Developed for Bacterial Respiratory Infections With Support From National Institute of Allergy and Infectious Diseases

Short Interest In Tetraphase Pharmaceuticals Decreases By 10.6%

Short Interest In Tetraphase Pharmaceuticals Decreases By 10.6%

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 636,108 share decrease in total short interest for Tetraphase Pharmaceuticals, Inc , to 5,379,230, a decrease of 10.57% since 12/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Tetraphase Pharmaceuticals, Inc. And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Tetraphase Pharmaceuticals, Inc. And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Tetraphase Pharmaceuticals, Inc.

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look poised to break out and trade higher from current levels.

5 Biotech Stocks Under $10 Triggering Breakout Trades

5 Biotech Stocks Under $10 Triggering Breakout Trades

Keep these under-$10 biotech stocks on your breakout trading radar.

Tetraphase Pharmaceuticals (TTPH) Is Today's Dead Cat Bounce Stock

Tetraphase Pharmaceuticals (TTPH) Is Today's Dead Cat Bounce Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Tetraphase Pharmaceuticals (TTPH) Showing Signs Of Perilous Reversal Today

Tetraphase Pharmaceuticals (TTPH) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "perilous reversal" (up big yesterday but down big today) candidate

10 Worst NASDAQ Biotech Stocks in the Third Quarter

10 Worst NASDAQ Biotech Stocks in the Third Quarter

The third quarter was brutal for biotech stocks. Here are the companies that fared the worst.

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Jim Cramer's 'Mad Money' Recap: Why Small Private Companies Should Be on Your Radar

Jim Cramer's 'Mad Money' Recap: Why Small Private Companies Should Be on Your Radar

Up-and-coming private companies are 'disruptors' that can take on their publicly traded peers like an oncoming train, Cramer says.

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Tetraphase Pharmaceuticals (TTPH) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

Today's Weak On High Volume Stock: Tetraphase Pharmaceuticals (TTPH)

Today's Weak On High Volume Stock: Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Perilous Reversal Watch: Tetraphase Pharmaceuticals (TTPH)

Perilous Reversal Watch: Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "perilous reversal" (up big yesterday but down big today) candidate

Tetraphase Pharmaceuticals (TTPH) Is Strong On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Is Strong On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a strong on high relative volume candidate

Tetraphase Executive Profits Hours Before Stock Plummets

Tetraphase Executive Profits Hours Before Stock Plummets

A Tetraphase insider executed a well-timed insider stock sale right before the company's share price fell on negative clinical trial results.

Today's Dead Cat Bounce Stock Is Tetraphase Pharmaceuticals (TTPH)

Today's Dead Cat Bounce Stock Is Tetraphase Pharmaceuticals (TTPH)

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a "dead cat bounce" (down big yesterday but up big today) candidate

TheStreet Quant Rating: D (Sell)